ONCLIVE NEWS NETWORK: ON LOCATION WILL BE LIVE AT ESMO THIS WEEK - STAY TUNED FOR MORE INFORMATION!

Dr. Haldorsen on the Contributions of Imaging in Endometrial Cancer

Ingfrid Haldorsen, MD
Published: Tuesday, Jan 23, 2018



Ingfrid Haldorsen, MD, University of Bergen, Haukeland University Hospital, discusses the contributions of imaging in endometrial cancer.

Haldorsen says that she hopes these advances in imaging give more certainty to the surgeon regarding the stage and prognosis prior to surgery. Additionally, these advances may be able to provide more prognostic tools with which to guide adjuvant therapy after primary surgery.

Investigators are currently exploring the efficacy of various imaging technologies in the diagnosis of endometrial cancer such as PET/MRI and 3D ultrasounds. Specifically, there is a diagnostic study evaluating the accuracy of 3D ultrasounds in comparison with MRI and final histology to detect myometrial invasion of endometrial cancer (NCT03207061).

Ultimately, imaging is very important when it comes to detecting recurrent disease, Haldorsen says. Every patient should have access to imaging facilities in order to get optimal treatment, and the implications of imaging should be kept in mind by the clinician, concludes Haldorsen.
 


Ingfrid Haldorsen, MD, University of Bergen, Haukeland University Hospital, discusses the contributions of imaging in endometrial cancer.

Haldorsen says that she hopes these advances in imaging give more certainty to the surgeon regarding the stage and prognosis prior to surgery. Additionally, these advances may be able to provide more prognostic tools with which to guide adjuvant therapy after primary surgery.

Investigators are currently exploring the efficacy of various imaging technologies in the diagnosis of endometrial cancer such as PET/MRI and 3D ultrasounds. Specifically, there is a diagnostic study evaluating the accuracy of 3D ultrasounds in comparison with MRI and final histology to detect myometrial invasion of endometrial cancer (NCT03207061).

Ultimately, imaging is very important when it comes to detecting recurrent disease, Haldorsen says. Every patient should have access to imaging facilities in order to get optimal treatment, and the implications of imaging should be kept in mind by the clinician, concludes Haldorsen.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Oncology Best Practice™: Expert Perspectives to Incorporate Evidence on PARP Inhibitors into Practice and Optimize the Medical Management of Ovarian CancerOct 31, 20181.0
Publication Bottom Border
Border Publication
x